Sensus Healthcare, Inc. SRTS
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 161.79% | -32.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 161.79% | -32.53% | |||
| Cost of Revenue | 77.98% | -36.70% | |||
| Gross Profit | 327.57% | -22.40% | |||
| SG&A Expenses | 33.84% | -24.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.20% | -29.44% | |||
| Operating Income | 49.09% | 27.03% | |||
| Income Before Tax | 51.26% | 27.64% | |||
| Income Tax Expenses | -- | 453.83% | |||
| Earnings from Continuing Operations | 82.94% | -233.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 82.94% | -233.17% | |||
| EBIT | 49.09% | 27.03% | |||
| EBITDA | 50.29% | 27.40% | |||
| EPS Basic | 82.94% | -233.23% | |||
| Normalized Basic EPS | 51.25% | 27.63% | |||
| EPS Diluted | 82.94% | -232.19% | |||
| Normalized Diluted EPS | 51.25% | 27.63% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||